High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer. (2nd January 2017)

• Record Type: Journal Article
• Authors: Sun, Cheng; Xu, Jing; Huang, Qiang; Huang, Mei; Wen, Hao; Zhang, Chuanshan; Wang, Jinyu; Song, Jiaxi; Zheng, Meijuan; Sun, Haoyu; Wei, Haiming; Xiao, Weihua; Sun, Rui; Tian, Zhigang
• Is Part Of: Oncoimmunology. Volume 6:Number 1(2017)
• Publication Date: 2017-01-02
• Subjects: Hepatocellular carcinoma -- HLA-E -- NK cells -- NKG2A -- prognosis; Tumors -- Immunological aspects -- Periodicals; Neoplasms -- therapy -- Periodicals; Immunotherapy -- Periodicals; 616.994
• DOI: 10.1080/2162402X.2016.1264562
• Languages: English
• ISSNs: 2162-402X

Abstract

ABSTRACT: Background and Aims : As the predominant lymphocyte subset in the liver, natural killer (NK) cells have been shown to be highly associated with the outcomes of patients with chronic hepatitis B virus infection (CHB) and hepatocellular carcinoma (HCC). Previously, we reported that NKG2A, a checkpoint candidate, mediates human and murine NK cell dysfunction in CHB. However, NK cell exhaustion and, particularly, the level of NKG2A expression within liver tumors have not been reported. Methods : In this study, we analyzed NKG2A expression and the related dysfunction of NK cells located in intra- or peritumor regions of liver tissue samples from 207 HCC patients, in addition to analyzing disease outcomes. Results : The expression of NKG2A in NK cells and the NKG2A ligand, HLA-E, in intratumor HCC tissues was observed to be increased. These NK cells, and particularly CD56 dim NK cells, with higher NKG2A expression showed features of functional exhaustion and were associated with a poor prognosis. The increase in NKG2A expression might be induced by IL-10, which was present at a high level in the plasma of HCC patients. Blocking IL-10 could specifically inhibit NKG2A expression in NK cells. Conclusions : These findings indicate that NKG2A expression is influenced by factors from cancer nests and contributes to NK cell exhaustion, suggesting that NKG2A blockade has the potential to restore immunity against liver tumors by reversing NK cell exhaustion.